JP Morgan Maintains Neutral on Sotera Health, Raises Price Target to $18
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Neutral and raises the price target from $16 to $18.
JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Neutral and raises the price target from $16 to $18.